Karmanos Cancer Institute Appoints New Oncology Leader to Expand…

Event summary

Karmanos Cancer Institute appoints Dr. Stefan Grant as associate center director and medical director of the Karmanos Cancer Network, effective September 2026.
Dr. Grant brings three decades of experience in clinical trial leadership and lung cancer expertise, previously serving as co-director of the Louisiana Cancer Research Center.
New role focuses on expanding clinical trial access and oncology operations across Karmanos' 13 Michigan locations outside metro Detroit.
Dr. Grant co-leads the Thoracic Oncology Multidisciplinary Team and is a member of the Phase I Clinical Trials MDT.
Karmanos aims to reduce patient travel for clinical trials by increasing access at network locations.

The big picture

Karmanos Cancer Institute's appointment of Dr. Stefan Grant underscores its commitment to expanding clinical trial access and strengthening its oncology network. This move aligns with broader industry trends toward decentralized clinical trials and increased focus on patient-centered care. As part of McLaren Health Care, Karmanos aims to leverage its comprehensive cancer center designation to enhance its competitive position in Michigan's healthcare landscape.

What we're watching

Clinical Trial Expansion: How Karmanos will measure the success of its initiative to bring clinical trials closer to patients in non-metro Detroit locations.
Leadership Integration: Whether Dr. Grant's extensive experience in NCI-designated centers will accelerate Karmanos' research and operational goals.
Competitive Positioning: The pace at which Karmanos can differentiate itself from other comprehensive cancer centers in Michigan and beyond.